PARADIGM CAPITAL MANAGEMENT LIVE WITH INDATA
Implements INDATA SaaS on a Front-to-Back Office
Basis delivered via iPM Private Cloud
With a three-decade history of small-cap investing, Paradigm Capital Management, based in
Paradigm is using the INDATA system for a range of functions including trade order management (OMS), Portfolio Accounting, Performance and Reporting, including managed services for streamlined reconciliation.
"We are very pleased to have Paradigm Capital Management as a client. We look forward to partnering with Paradigm on their ongoing needs," commented
About INDATA®
INDATA is a leading specialized provider of SaaS (Software-as-a-Service), technology and managed outsourcing services for buyside firms, including trade order management (OMS), portfolio management, compliance, portfolio accounting and front-to-back office. INDATA iPM Portfolio Architect AI™ is the industry's first portfolio construction, modeling, rebalancing and reporting tool based on AI, and Machine Learning. INDATA's iPM – Intelligent Portfolio Management® technology platform allows end users to efficiently collaborate in real-time across the enterprise and contains the best of class functionality demanded by sophisticated institutional investors, wealth managers, and hedge funds. The company's mission is to provide clients with cutting edge technology products and services to increase trading and operational efficiency while reducing risk and administrative overhead.
INDATA provides software and services to a variety of buyside clients including asset managers, registered investment advisors, banks and wealth management firms, pension funds and hedge funds. Assets under management range from under
Media Contact:
View original content:https://www.prnewswire.com/news-releases/paradigm-capital-management-live-with-indata-302330839.html
SOURCE INDATA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AULUMU Introduces the ADuo Particle Aramid Fiber Case for iPhone Duo
- Endometriosis Pain Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie
- Elektros Celebrates 51.52% Daily Gain and Reaffirms Vision for Lithium and Next-Generation EV Charging
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Hedge FundsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share